CVM

CEL-SCI Corporation CVM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CVM NWBO CTXR CLDX CRDF AGEN CYCC BCRX
6M -13.89 % 2.87 % 30.85 % 58.97 % -10.53 % 133.53 % -88.90 % 5.87 %
YTD -34.89 % -9.08 % -68.30 % 3.80 % -48.12 % 28.48 % -92.85 % -7.79 %
1Y -73.31 % -12.78 % -86.16 % -11.59 % -15.97 % -16.07 % -96.68 % -3.22 %
3Y -91.47 % -63.04 % -95.49 % -12.26 % 35.58 % -92.19 % -99.86 % -47.79 %
5Y -98.20 % -77.73 % -95.27 % 58.50 % -86.63 % -95.44 % -99.95 % 87.53 %
10Y -98.43 % -95.89 % -99.81 % -86.08 % -99.46 % -95.81 % -100.00 % -20.75 %
From the beginning -99.69 % -99.98 % -99.67 % -96.95 % -99.86 % -99.95 % -100.00 % 11.08 %

Dividend

CEL-SCI Corporation

Cyclacel Pharmaceuticals, Inc.